Home

Case Study

Improving Early-stage Cancer Detection Rates with Federated Learning

Improving Early-stage Cancer Detection Rates with Federated Learning

Intel
Pages 4 Pages

To address low early-stage cancer detection rates in Malaysia, QMed Asia, JelloX Biotech, and Intel partnered to develop MetaLite®, a federated learning-based 3D diagnostics platform. Deployed at major hospitals, MetaLite digitizes and analyzes medical images securely across sites, enabling accurate, real-time AI-assisted diagnosis for cervical and lung cancer. Powered by Intel® Xeon® processors and protected by Intel® SGX, the system improves accessibility, privacy, and diagnostic precision while minimizing infrastructure complexity—advancing digital healthcare transformation in underserved regions.

Join for free to read

You Might Also Like


Improving Early-Stage Cancer Detection Rates with Federated Learning
Case Study Improving Early-Stage Cancer Detection Rates with Federated…
Intel

Early Stage Cancer Screening
Case Study Early Stage Cancer Screening
Diamond Light Source LTD

Improving Screening for Lung Cancer Enables Early Detection
Case Study Improving Screening for Lung Cancer Enables Early Detection
HealthCatalyst

Early cancer detection starts in everyday places
White Paper Early cancer detection starts in everyday places
Color

More from Intel


Improving Early-Stage Cancer Detection Rates with Federated Learning
Case Study Improving Early-Stage Cancer Detection Rates with Federated…
Intel

Accelerating Secure Computing for Federated Learning
Case Study Accelerating Secure Computing for Federated Learning
Intel

Breakthrough in Cancer Screening Using Deep Learning
Case Study Breakthrough in Cancer Screening Using Deep Learning
Intel

Anodot Boosts Machine Learning Anomaly Detection and Forecasting Performance
Case Study Anodot Boosts Machine Learning Anomaly Detection and Forecasting…
Intel
© 2025 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info